307 related articles for article (PubMed ID: 9051299)
1. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
[TBL] [Abstract][Full Text] [Related]
2. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
3. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
5. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
6. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Griesbacher T; Legat FJ
Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
[TBL] [Abstract][Full Text] [Related]
7. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
[TBL] [Abstract][Full Text] [Related]
8. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
[TBL] [Abstract][Full Text] [Related]
9. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
Griesbacher T; Amann R; Sametz W; Diethart S; Juan H
Br J Pharmacol; 1998 Jul; 124(6):1328-34. PubMed ID: 9720808
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
[TBL] [Abstract][Full Text] [Related]
11. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
12. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4053-61. PubMed ID: 9767642
[TBL] [Abstract][Full Text] [Related]
13. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
[TBL] [Abstract][Full Text] [Related]
14. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
[TBL] [Abstract][Full Text] [Related]
15. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
17. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
[TBL] [Abstract][Full Text] [Related]
18. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
19. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
